UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Patient-centered Communication About Healthy Weight in Early Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Other: Focus Group

First Posted Date: 2020-08-07

Last Posted Date: 2022-07-29

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 39

Registration Number: NCT04504201

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Effect of Incidental Findings Information on Lung Cancer Screening Intent

Not Applicable

Completed

Conditions: Decision Support Techniques
Neoplasm of Lung
Mass Screening

Interventions: Behavioral: Lung Cancer Screening Decision Aid without Incidental Findings Information
Behavioral: Lung Cancer Screening Decision Aid with Incidental Findings Information

First Posted Date: 2020-06-16

Last Posted Date: 2020-12-10

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 419

Registration Number: NCT04432753

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)

Not Applicable

Active, not recruiting

Conditions: Colorectal Cancer

Interventions: Behavioral: Sub-Study Mailed FIT Intervention Enhanced Envelope - Age Group 45-49
Behavioral: Trial Mailed FIT Intervention - Age Group 50-75
Behavioral: Sub-Study Mailed FIT Active Comparator Plain Envelope - Age Group 45-49

First Posted Date: 2020-05-28

Last Posted Date: 2024-06-25

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 4318

Registration Number: NCT04406714

Locations: 🇺🇸
Blue Ridge Health, Hendersonville, North Carolina, United States
🇺🇸
Roanoke Chowan Community Health Center, Ahoskie, North Carolina, United States

Reverse Axillary Mapping in Breast Radiation Treatment Planning

Withdrawn

Conditions: Lymphedema
Breast Cancer

First Posted Date: 2020-03-03

Last Posted Date: 2021-05-27

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Registration Number: NCT04292860

Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer

Not Applicable

Terminated

Conditions: Bladder Cancer

Interventions: Other: Targeted Interventions for Impairments Identified During Geriatric Assessment

First Posted Date: 2020-02-18

Last Posted Date: 2021-10-18

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 5

Registration Number: NCT04273724

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia

Completed

Conditions: Cervix Lesion
Cervical Cancer

Interventions: Diagnostic Test: digital PCR (dPCR) assay

First Posted Date: 2020-02-18

Last Posted Date: 2024-11-14

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 145

Registration Number: NCT04274465

Locations: 🇺🇸
Tuvara Jenene King, Chapel Hill, North Carolina, United States

PET/MR Characterization of Renal Cell Carcinomas

Not Applicable

Terminated

Conditions: Renal Cell Carcinoma

Interventions: Diagnostic Test: PET/MR

First Posted Date: 2020-02-17

Last Posted Date: 2023-08-24

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 5

Registration Number: NCT04271254

Locations: 🇺🇸
UNC- Chapel Hill, Chapel Hill, North Carolina, United States

PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: 68Ga-HBED-CC-PSMA

First Posted Date: 2019-11-25

Last Posted Date: 2024-03-25

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 9

Registration Number: NCT04176497

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

3-D Super Resolution Ultrasound Microvascular Imaging

Phase 2

Active, not recruiting

Conditions: Breast Cancer
Thyroid Cancer

Interventions: Drug: Definity
Device: Acoustic Angiography

First Posted Date: 2019-10-23

Last Posted Date: 2024-11-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 27

Registration Number: NCT04136912

Locations: 🇺🇸
Univeristy of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States

Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Early Phase 1

Active, not recruiting

Conditions: Relapsed Hodgkin Lymphoma
Refractory Hodgkin Lymphoma

Interventions: Biological: Nivolumab
Biological: Pembrolizumab

First Posted Date: 2019-10-22

Last Posted Date: 2024-12-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 10

Registration Number: NCT04134325

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy